Brown, Lisle/Cummings’s BlackRock Health Sciences Trust II BMEZ Stock Holding History
Bought
Maintained
Sold
Other funds holding BMEZ
SCM
RCM
PCM
Brown, Lisle/Cummings's BMEZ Position: Q2 2026 in Review
Brown, Lisle/Cummings increased its BlackRock Health Sciences Trust II (BMEZ) stake by 7.8% in Q2 2026, buying an estimated $59.1K and bringing the position to 57,026 shares worth $875K. The position accounts for 0.2% of the portfolio, ranked #115.
Brown, Lisle/Cummings first reported a position in BMEZ in Q4 2021 and has held it in 19 quarters since. 89 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.
- Brown, Lisle/Cummings held 57,026 shares of BlackRock Health Sciences Trust II worth $875K as of Q2 2026.
- Brown, Lisle/Cummings bought 4,108 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $59.1K.
- BlackRock Health Sciences Trust II made up 0.2% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #115 holding.
- Brown, Lisle/Cummings first reported a position in BlackRock Health Sciences Trust II in Q4 2021 and has held it in 19 quarters since.
- 89 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.
Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.